Search
-
Respiratory Syncytial Virus : The race to market continues
The first wave of Ipsos’s Syndicated Global RSV study, fielded in 8 markets in Europe.
-
Innovation that speaks for itself
How pharma earned people’s trust? Our data shows that pharma is the most trusted sector of those we measure.
-
Global Trends about Polarization: A Divided World
We share so many of the same values, but feelings of division persist
-
Data Dive: trust in dangerous times
In three infographics, we look at what Ipsos’ global polling reveals about how people feel about public and private institutions, as well as each other, as world leaders gather in Davos.
-
A global perspective: all is not lost
Trust continues to be on the rise for almost all sectors and institutions measured this year.
-
Trust in professions: a return to the status quo ante
Many professions have seen little to no impact on their trustworthiness scores.
-
RSV: On the verge of change
After decades of failed attempts, the respiratory syncytial virus (RSV) treatment and vaccine landscape is on the verge of profound change.
-
Has disruption become the new normal?
On March 11, 2020, the WHO declared the novel coronavirus (COVID-19) outbreak a global pandemic. Almost immediately, the pandemic rose to the top global concern in Ipsos’ What Worries the World poll.